Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

Healthcare Cannabis

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp > The success of LABS

<< Previous

Bullboard Posts

Next >>

Comment by Solid1on Apr 17, 2024 3:40am

98 Views

Post# 35993097

RE:RE:RE:RE:The success of LABS

And let's not forget Dr. Yasmin Hurd, a pioneer in addiction research who has been working with the FDA on the use of CBD since early 2023. Dr. Yasmin Hurd has also worked with Medipharm Labs (but that was a while ago). A very interesting development for me, especially in the area of opiate addiction and CBD.... John Hopkins has used Epidiolex in opiate addiction research, which the generic in the US could possibly relate to but all speculation with no news from Medipharm Labs and their pharma partner

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec